279 related articles for article (PubMed ID: 35354556)
1. Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study.
Potter AL; Rosenstein AL; Kiang MV; Shah SA; Gaissert HA; Chang DC; Fintelmann FJ; Yang CJ
BMJ; 2022 Mar; 376():e069008. PubMed ID: 35354556
[TBL] [Abstract][Full Text] [Related]
2. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
[TBL] [Abstract][Full Text] [Related]
3. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
4. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
[TBL] [Abstract][Full Text] [Related]
5. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
[TBL] [Abstract][Full Text] [Related]
6. Association of Stage Shift and Population Mortality Among Patients With Non-Small Cell Lung Cancer.
Flores R; Patel P; Alpert N; Pyenson B; Taioli E
JAMA Netw Open; 2021 Dec; 4(12):e2137508. PubMed ID: 34919136
[TBL] [Abstract][Full Text] [Related]
7. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract][Full Text] [Related]
8. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
Ganti AK; Klein AB; Cotarla I; Seal B; Chou E
JAMA Oncol; 2021 Dec; 7(12):1824-1832. PubMed ID: 34673888
[TBL] [Abstract][Full Text] [Related]
9. National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer.
Higgins KA; O'Connell K; Liu Y; Gillespie TW; McDonald MW; Pillai RN; Patel KR; Patel PR; Robinson CG; Simone CB; Owonikoko TK; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):128-137. PubMed ID: 27979443
[TBL] [Abstract][Full Text] [Related]
10. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.
Balekian AA; Wisnivesky JP; Gould MK
Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040
[TBL] [Abstract][Full Text] [Related]
11. Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review.
White LJ; Kaur A; Lapel RT; E Boswell G; Luceri RE; Parrish JS; Seda G
Mil Med; 2020 Jun; 185(5-6):e864-e869. PubMed ID: 31925432
[TBL] [Abstract][Full Text] [Related]
12. Shortage of thoracic surgeons in the United States: Implications for treatment and survival for stage I lung cancer patients.
Potter AL; Rosenstein AL; Kandala K; Venkateswaran S; Kiang MV; Okusanya OT; Auchincloss HG; Martin LW; Colson YL; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2024 May; 167(5):1603-1614.e9. PubMed ID: 37716651
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non-small cell lung cancer 2007-2016.
Shah M; Parmar A; Chan KKW
Cancer Med; 2020 May; 9(10):3407-3416. PubMed ID: 32196964
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
15. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
16. Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer.
Gray SW; Landrum MB; Lamont EB; McNeil BJ; Jaklitsch MT; Keating NL
Cancer; 2012 Mar; 118(5):1404-11. PubMed ID: 21800285
[TBL] [Abstract][Full Text] [Related]
17. Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
Gierada DS; Pinsky PF
Chest; 2021 Feb; 159(2):862-869. PubMed ID: 32822676
[TBL] [Abstract][Full Text] [Related]
18. Variable impact of prior cancer history on the survival of lung cancer patients.
Monsalve AF; Hoag JR; Resio BJ; Chiu AS; Brown LB; Detterbeck FC; Blasberg JD; Boffa DJ
Lung Cancer; 2019 Jan; 127():130-137. PubMed ID: 30642541
[TBL] [Abstract][Full Text] [Related]
19. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
[No Abstract] [Full Text] [Related]
20. Effect of stage shift and immunotherapy treatment on lung cancer survival outcomes.
Patel P; Flores R; Alpert N; Pyenson B; Taioli E
Eur J Cardiothorac Surg; 2023 Aug; 64(2):. PubMed ID: 37285318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
